Clinical Trial Update: Efficacy and Safety Study of TPX-115 on Partial-thickness Rotator Cuff Tear [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the efficacy and safety of TPX-115 for partial-thickness rotator cuff tears; the trial status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Partial-thickness Rotator Cuff Tears

Drugs mentioned

• TPX-115 (TPX-115)

Snippet

Sponsor: Tego Science, Inc. | Conditions: Partial Thickness Rotator Cuff Tears | Phase 2 | Status: NOT_YET_RECRUITING